Two crore COVID-19 vaccine doses will be procured through global tender in order to meet the increased demand and to facilitate vaccination of the age group of 18-44 years, Deputy Chief Minister and state COVID task force head CN Ashwath Narayan said on Tuesday. In addition to this, an order has already been been placed for three crore vaccine doses — one crore Covaxin and two crore Covishield, he said.
The decision was taken at a high-level meeting he chaired here, his office said in a statement. "Till now, we had depended only on vaccines supplied by the central government and it was not procured from the open market by floating tender. Now, it has been instructed to float the tender and to complete the process within seven days," Narayan said.
Authorities have also been instructed to procure one lakh pulse oximeters and these will be distributed to all the districts and taluks. It will be the responsibility of the District Health Officers and Taluk Health Officers to collect the pulse oximeters back after the infected user gets cured.
Later they will be used for creating a pulse oximeter bank, he said. Narayan said 10 lakhs of Ivermectin, the tablet which is required to treat the infected, has been procured and its supply will begin on May 14.
It has been further decided to procure 25 lakh tablets and make them available in all hospitals across the state. Thirty-five lakh zinc tablets and one crore Calcigen tablets will be procured and made available in all district hospitals, taluk hospitals, PHCs, and community health centres, Narayan said.
Currently, 10.50 lakh RAT (Rapid Antigen Tests) kits are in stock and this will be enough for seven days. A total of 50,000 RAT kits are being supplied every day. In addition to this, it has been decided to procure 37 lakh RT-PCR kits.
The minister said triaging would be made mandatory to avoid unnecessary occupancy of beds and requested urban residents not to go to villages to get vaccinated.
Read all the Latest News, Breaking News and Coronavirus News here. Follow us on Facebook, Twitter and Telegram.
Comments
0 comment